Clinical Trial Update: Exploratory Study of EBV-TCR-T Cell Injection for EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes an exploratory study of EBV-TCR-T cell therapy to treat EBV DNAemia after allogeneic hematopoietic stem cell transplantatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus Infection
• Post-transplant Lymphoproliferative Disorder

Drugs mentioned

• EBV-TCR-T cell therapy (EBV-TCR-T cell)

Snippet

Sponsor: Daihong Liu | Conditions: Epstein-Barr Virus Infection, Post-Transplant Lymphoproliferative Disorder | Phase 1, Phase 2 | Status: RECRUITING